MP
PLSE icon

Mangrove Partners’s Pulse Biosciences PLSE Stock Holding History

Mangrove Partners’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$849K Buy
+30,612
New +$722K 0.06% 139

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mangrove Partners's PLSE Position: Q2 2026 in Review

Mangrove Partners opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 30,612 shares worth $849K. The stake represents 0.06% of the portfolio and ranks #139 among its holdings.

106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Mangrove Partners held 30,612 shares of Pulse Biosciences worth $849K as of Q2 2026.
  • Pulse Biosciences was a new Mangrove Partners position in Q2 2026.
  • Pulse Biosciences made up 0.06% of Mangrove Partners's portfolio in Q2 2026, its #139 holding.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.